285 related articles for article (PubMed ID: 34617293)
21. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
[TBL] [Abstract][Full Text] [Related]
22. Anti-HMGCR myopathy: barriers to prompt recognition.
Barp A; Merve A; Shah S; Desikan M; Hanna MG; Bugiardini E
Pract Neurol; 2023 Jun; 23(3):239-242. PubMed ID: 36564213
[TBL] [Abstract][Full Text] [Related]
23. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
[TBL] [Abstract][Full Text] [Related]
24. Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.
Ma X; Bu BT
Front Immunol; 2022; 13():1019972. PubMed ID: 36311711
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
[TBL] [Abstract][Full Text] [Related]
26. [Anti-HMGCR immune-mediated necrotizing myopathy: A case report].
Zhang YJ; Ma JY; Liu XY; Zheng DF; Zhang YS; Li XG; Fan DS
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):558-562. PubMed ID: 37291935
[TBL] [Abstract][Full Text] [Related]
27. Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case Report.
Belkhribchia MR; Lobrinus JA; Semlil L; Chauveau N; Ajrinija A; Egervari K; Ennhaili ZE
J Investig Med High Impact Case Rep; 2024; 12():23247096241231646. PubMed ID: 38353222
[TBL] [Abstract][Full Text] [Related]
28. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.
Iriki J; Yamamoto K; Senju H; Nagaoka A; Yoshida M; Iwasaki K; Ashizawa N; Hirayama T; Tashiro M; Takazono T; Imamura Y; Miyazaki T; Izumikawa K; Yanagihara K; Tsujino A; Fukuoka J; Uetani M; Satoh M; Mukae H
Int J Infect Dis; 2021 Feb; 103():33-36. PubMed ID: 33217572
[TBL] [Abstract][Full Text] [Related]
29. A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysis.
Sasaki R; Yunoki T; Nakano Y; Fukui Y; Takemoto M; Morihara R; Katsuyama E; Nishino I; Yamashita T
Neuromuscul Disord; 2023 Feb; 33(2):183-186. PubMed ID: 36652875
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
Mammen AL
Nat Rev Neurol; 2011 Jun; 7(6):343-54. PubMed ID: 21654717
[TBL] [Abstract][Full Text] [Related]
31. [Immune-Mediated Necrotizing Myopathy: IMNM].
Tomimitsu H
Brain Nerve; 2021 Feb; 73(2):127-136. PubMed ID: 33561827
[TBL] [Abstract][Full Text] [Related]
32. [Immune-Mediated Necrotizing Myopathy].
Uruha A
Brain Nerve; 2024 May; 76(5):646-654. PubMed ID: 38741508
[TBL] [Abstract][Full Text] [Related]
33. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins.
Khan F; Brady S; Kuttikat A
Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115
[TBL] [Abstract][Full Text] [Related]
34. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
Basharat P; Christopher-Stine L
Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
[TBL] [Abstract][Full Text] [Related]
35. Anti-HMGCR myopathy: clinical and histopathological features, and prognosis.
Kurashige T
Curr Opin Rheumatol; 2021 Nov; 33(6):554-562. PubMed ID: 34456255
[TBL] [Abstract][Full Text] [Related]
36. Pathologic Features of Anti-Ku Myositis.
Oyama M; Holzer MT; Ohnuki Y; Saito Y; Nishimori Y; Suzuki S; Shiina T; Leonard-Louis S; Benveniste O; Schneider U; Stenzel W; Nishino I; Suzuki S; Uruha A
Neurology; 2024 Apr; 102(8):e209268. PubMed ID: 38547417
[TBL] [Abstract][Full Text] [Related]
37. Granulomatous myopathy co-existent immune-mediated necrotizing myopathy: A case report.
Yin C; Yin S; Zheng D; Huang L; Fu Q
Clin Neurol Neurosurg; 2023 Sep; 232():107844. PubMed ID: 37421929
[TBL] [Abstract][Full Text] [Related]
38. Immune Mediated Necrotizing Myopathy: Where do we Stand?
Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
[TBL] [Abstract][Full Text] [Related]
39. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
Cui BB; Tian YR; Ma XY; Yin G; Xie Q
Front Immunol; 2021; 12():777502. PubMed ID: 34925350
[TBL] [Abstract][Full Text] [Related]
40. Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy.
Kurashige T; Nakamura R; Murao T; Mine N; Sato M; Katsumata R; Kanaya Y; Dodo Y; Sugiura T; Ohshita T
BMC Immunol; 2024 May; 25(1):30. PubMed ID: 38734636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
